InfuSystem Holdings (INFU) Deferred Taxes (2010 - 2026)
InfuSystem Holdings (INFU) posted Deferred Taxes of $400000.0 for Q1 2026, up 104.08% on a QoQ basis from $196000.0 in Q4 2025, and down 23.08% year-over-year from $520000.0 in Q1 2025.
InfuSystem Holdings (INFU) Deferred Taxes (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Deferred Taxes history runs 11 years deep, the most recent figure standing at $400000.0 for Q1 2026.
- Quarterly Deferred Taxes fell 23.08% year-over-year to $400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 0.69% YoY) and the FY2025 annual result came in at $2.7 million, up 42.13% from the prior year.
- Deferred Taxes was $400000.0 for Q1 2026 at InfuSystem Holdings, up from $196000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $1.2 million in Q3 2025 and bottomed at -$462000.0 in Q1 2022.
- A 5-year average of $335058.8 and a median of $350000.0 in 2022 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2022 — Deferred Taxes slumped 156.67% — and 2023, when it soared 625.93%.
- InfuSystem Holdings' Deferred Taxes stood at $350000.0 in 2022, then decreased by 12.0% to $308000.0 in 2023, then surged by 73.7% to $535000.0 in 2024, then sank by 63.36% to $196000.0 in 2025, then surged by 104.08% to $400000.0 in 2026.
- Business Quant data shows INFU's Deferred Taxes at $400000.0 in Q1 2026, $196000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 7.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 196,000.00 |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 843,000.00 |
| Mar 31, 2025 | 520,000.00 |
| Dec 31, 2024 | 535,000.00 |
| Sep 30, 2024 | 978,000.00 |
| Jun 30, 2024 | 591,000.00 |
| Mar 31, 2024 | -186,000.00 |
| Dec 31, 2023 | 308,000.00 |
| Sep 30, 2023 | 431,000.00 |
| Jun 30, 2023 | 196,000.00 |
| Mar 31, 2023 | -302,000.00 |
| Dec 31, 2022 | 350,000.00 |
| Sep 30, 2022 | 104,000.00 |
| Jun 30, 2022 | 27,000.00 |
| Mar 31, 2022 | -462,000.00 |
| Dec 31, 2021 | 722,000.00 |
| Sep 30, 2021 | -217,000.00 |
| Jun 30, 2021 | -478,000.00 |